Astec Lifesciences Ltd
Astec Lifesciences Ltd (ASTEC) last traded at ₹596, a market capitalisation of ₹1,328 crore. Over the past 52 weeks the stock has ranged between ₹512 and ₹942. Astec Lifesciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹84 crore and net profit of ₹-19 crore. Figures are as of 25 Aug 2026 and are not real time.
Astec Lifesciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Astec Lifesciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹84 cr, down 7.7% from ₹91 cr a year earlier. Net profit was ₹-19 cr, up 42.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 99 | 94 | 120 | 91 | 74 | 125 | 159 | 84 |
| Expenses | 118 | 100 | 114 | 102 | 80 | 121 | 149 | 84 |
| Operating profit | -20 | -6 | 6 | -11 | -7 | 4 | 9 | -1 |
| OPM % | -20% | -6% | 4.6% | -12% | -9% | 3.2% | 6% | -0.8% |
| Other income | 2 | 2 | 1 | 1 | 1 | -1 | 3 | 1 |
| Interest | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 |
| Depreciation | 11 | 11 | 12 | 11 | 10 | 11 | 12 | 11 |
| Profit before tax | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 |
| Tax % | 0% | 61% | 3% | 0% | 0% | 0% | -2% | -0% |
| Net profit | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 |
| EPS (₹) | -17.21 | -18.03 | -7.18 | -14.75 | -10.96 | -7.05 | -3.48 | -8.40 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Astec Lifesciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 555 | 677 | 628 | 458 | 381 | 448 | 441 |
| Operating profit | 112 | 154 | 77 | -6 | -66 | -4 | 6 |
| OPM % | 20% | 23% | 12% | -1.3% | -17% | -1.0% | 1.3% |
| Net profit | 65 | 90 | 26 | -47 | -135 | -81 | -67 |
| EPS (₹) | 29.04 | 40.12 | 11.41 | -20.95 | -60.16 | -36.32 | -29.89 |
TTM is the trailing twelve months to the most recent quarter.
Astec Lifesciences Ltd growth and returns
- 10 Years
- 7%
- 5 Years
- -4%
- 3 Years
- -11%
- TTM
- 9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 50%
- 10 Years
- 4%
- 5 Years
- -14%
- 3 Years
- -23%
- 1 Year
- -32%
- 10 Years
- 2%
- 5 Years
- -8%
- 3 Years
- -26%
- Last Year
- -25%
Astec Lifesciences Ltd shareholding pattern
Promoters held 71.97% at Jun 2026, up from 70.87% at Jun 2025. FIIs 0.01% and DIIs 3.33%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 66.74% | 66.74% | 70.87% | 70.87% | 72.42% | 71.97% | 71.97% | 71.97% |
| FIIs | 0.53% | 1.20% | 0.25% | 0.02% | 0.00% | 0.04% | 0.03% | 0.01% |
| DIIs | 4.50% | 5.40% | 4.34% | 4.26% | 4.01% | 3.17% | 3.33% | 3.33% |
| Public | 28.20% | 26.64% | 24.53% | 24.84% | 23.57% | 24.82% | 24.67% | 24.69% |
| No. of shareholders | 19,727 | 19,057 | 18,689 | 18,549 | 18,276 | 22,293 | 21,041 | 19,889 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Track Astec Lifesciences Ltd
Cruxal reads every Astec Lifesciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.